Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$22.28 -0.04 (-0.18%)
Closing price 03:57 PM Eastern
Extended Trading
$22.35 +0.07 (+0.31%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. STVN, GKOS, IRTC, NARI, TMDX, BLCO, SLNO, INSP, NVST, and PRCT

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Stevanato Group (NYSE:STVN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Stevanato Group has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.09, suggesting that its stock price is 109% more volatile than the S&P 500.

93.2% of Warby Parker shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by company insiders. Comparatively, 18.2% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Stevanato Group has a net margin of 11.14% compared to Warby Parker's net margin of -1.79%. Stevanato Group's return on equity of 10.00% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.14% 10.00% 6.03%
Warby Parker -1.79%-2.48%-1.29%

Warby Parker has a consensus target price of $22.88, suggesting a potential upside of 2.67%. Given Warby Parker's higher possible upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
Warby Parker
0 Sell rating(s)
7 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.61

In the previous week, Warby Parker had 1 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Warby Parker and 3 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.54 beat Warby Parker's score of 0.62 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Warby Parker
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.19B6.38€127.45M€0.5149.33
Warby Parker$771.32M3.02-$20.39M-$0.12-185.67

Summary

Stevanato Group beats Warby Parker on 11 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.33B$33.63B$16.23B$20.51B
Dividend YieldN/A2.70%3.12%3.73%
P/E Ratio-185.6732.4419.9127.90
Price / Sales3.021.8448.1840.92
Price / Cash65.7516.3214.6722.25
Price / Book6.658.776.114.59
Net Income-$20.39M$1.19B$680.31M$982.91M
7 Day Performance1.46%-0.44%-1.01%0.74%
1 Month Performance-0.86%1.05%-0.83%3.94%
1 Year Performance41.73%35.11%6.89%14.82%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
1.9316 of 5 stars
$22.28
-0.2%
$22.88
+2.7%
+45.0%$2.33B$771.32M-185.673,780Positive News
STVN
Stevanato Group
1.1556 of 5 stars
€24.51
-0.5%
N/A+35.0%€7.42B€1.19B48.065,521
GKOS
Glaukos
4.377 of 5 stars
$103.42
+2.0%
$134.67
+30.2%
-16.3%$5.80B$383.48M-43.64780
IRTC
iRhythm Technologies
1.0339 of 5 stars
$153.96
-0.5%
$138.60
-10.0%
+40.4%$4.94B$591.84M-49.032,000
NARI
Inari Medical
N/A$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
TMDX
TransMedics Group
1.7035 of 5 stars
$134.01
+1.9%
$127.33
-5.0%
-16.4%$4.45B$441.54M98.54210
BLCO
Bausch + Lomb
2.9341 of 5 stars
$13.03
+5.1%
$15.54
+19.3%
-8.2%$4.39B$4.79B25.8313,500Analyst Forecast
High Trading Volume
SLNO
Soleno Therapeutics
4.4392 of 5 stars
$83.78
+0.6%
$107.10
+27.8%
+101.0%$4.20BN/A-18.1330
INSP
Inspire Medical Systems
4.811 of 5 stars
$129.28
-2.4%
$211.91
+63.9%
-1.7%$3.91B$802.80M59.581,246News Coverage
Positive News
NVST
Envista
3.9255 of 5 stars
$19.58
-0.5%
$20.23
+3.3%
+22.8%$3.33B$2.51B-3.0012,300Analyst Forecast
PRCT
PROCEPT BioRobotics
2.6993 of 5 stars
$57.60
+1.2%
$90.00
+56.3%
-9.8%$3.15B$224.50M-33.88430News Coverage
Analyst Forecast

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners